Shell Asset Management CO Agios Pharmaceuticals, Inc. Transaction History

Shell Asset Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$44.23 - $57.5 $261,620 - $340,112	-5,915 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$34.45 - $53.48 $2,618 - $4,064	-76 Reduced 1.27%	5,915 $316,000
Q1 2020 May 11, 2020	SELL	$31.52 - $53.81 $2,868 - $4,896	-91 Reduced 1.5%	5,991 $213,000
Q4 2019 Feb 13, 2020	SELL	$30.08 - $50.59 $4,301 - $7,234	-143 Reduced 2.3%	6,082 $290,000
Q3 2019 Nov 12, 2019	SELL	$32.4 - $49.58 $1,717 - $2,627	-53 Reduced 0.84%	6,225 $202,000
Q2 2019 Aug 12, 2019	SELL	$46.17 - $68.1 $6,556 - $9,670	-142 Reduced 2.21%	6,278 $313,000
Q4 2018 Feb 13, 2019	SELL	$42.73 - $76.53 $21,365 - $38,265	-500 Reduced 7.23%	6,420 $296,000
Q3 2018 Nov 13, 2018	BUY	$71.67 - $91.95 $495,956 - $636,294	6,920 New	6,920 $534,000

226

56.3M

275K

251K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.5B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.